Enrolling by invitationNCT05368220
Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
Studying MODY
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Copenhagen
- Principal Investigator
- Torben Hansen, PhDUniversity of Copenhagen
- Intervention
- Whole genome sequencing(other)
- Enrollment
- 6500 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2027
Study locations (5)
- Rigshospitalet, Copenhagen, Denmark
- Herlev Hospital, Herlev, Denmark
- Steno Diabetes Center Copenhagen, Herlev, Denmark
- Hillerød Hospital, Hillerød, Denmark
- Hvidovre Hospital, Hvidovre, Denmark
Collaborators
Steno Diabetes Center Copenhagen · BGI Europe · Intomics A/S · Rigshospitalet, Denmark · Danish National Genome Center · Nordsjaellands Hospital · Herlev Hospital · Hvidovre University Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05368220 on ClinicalTrials.govOther trials for MODY
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT07452887Education and Mobile Reminder Program for Foot Self-Care in Type 2 DiabetesSelma Sahin
- RECRUITINGNANCT07195994A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 DiabetesQuickSilver Scientific
- ACTIVE NOT RECRUITINGNANCT07530575Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCOPINER Pastor Manfredi Winery
- ACTIVE NOT RECRUITINGPHASE1NCT07137585A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or ObesityHoffmann-La Roche
- RECRUITINGPHASE4NCT07112339A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesNovo Nordisk A/S
- RECRUITINGEARLY PHASE1NCT06609356Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 DiabetesVanderbilt University Medical Center
- RECRUITINGNANCT06118931Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic ControlUniversity of Toronto
- RECRUITINGNANCT06999356Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose MonitoringSutter Health